Soumya Eswaran
Tue, July 21, 2026 astatine 9:25 AM CDT 3 min read
In its Q2 2026 capitalist letter, NZS Growth Equity Strategy highlighted stocks similar Axogen, Inc. (NASDAQ:AXGN). Axogen, Inc. (NASDAQ:AXGN) is simply a biotechnology and aesculapian services institution that develops and commercializes technologies for peripheral nervus regeneration and repair. On July 20, 2026, Axogen, Inc. (NASDAQ:AXGN) closed astatine $39.48 per share. One-month instrumentality of Axogen, Inc. (NASDAQ:AXGN) was -11.66%, and its shares gained 214.83% implicit the past 52 weeks. Axogen, Inc. (NASDAQ:AXGN) has a marketplace capitalization of $2.1 billion.
NZS Growth Equity Strategy stated the pursuing regarding Axogen, Inc. (NASDAQ:AXGN) successful its Q2 2026 capitalist update:
"New additions to the portfolio were optionality positions successful Axogen, Inc. (NASDAQ:AXGN). Axogen provides nervus grafts utilized for peripheral nervus repair. Following BLA support of their Avance nervus allograft and related affirmative momentum successful security coverage, we deliberation Axogen is highly asymmetric to a aboriginal wherever nervus repair becomes standard-of-care, including for patients undergoing a mastectomy oregon prostatectomy (PSA to look into Axogen's tech if you oregon idiosyncratic you cognize could benefit). WuXi XDC is simply a China-based Contract Research, Development, and Manufacturing Organization (CRDMO) focused connected bioconjugates, an breathtaking probe country that is rapidly processing caller therapies. The aforementioned U.S. BIOSECURE Act provided america an charismatic introduction constituent into this rapidly increasing concern and volition besides support a lid connected presumption size fixed the scope of outcomes. In short, we deliberation a modestly higher dose of this "quality growth" assemblage is bully for our portfolio's health, and we've been incrementally expressing this view."
Axogen, Inc. (NASDAQ:AXGN) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 36 hedge money portfolios held Axogen, Inc. (NASDAQ:AXGN) astatine the extremity of the archetypal quarter, up from 26 successful the erstwhile quarter. While we admit the imaginable of Axogen, Inc. (NASDAQ:AXGN) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

2 months ago
24








English (CA) ·
English (US) ·
Spanish (MX) ·